• LAST PRICE
    5.3000
  • TODAY'S CHANGE (%)
    Trending Up0.0850 (1.6299%)
  • Bid / Lots
    5.0100/ 1
  • Ask / Lots
    6.0500/ 1
  • Open / Previous Close
    5.2111 / 5.2150
  • Day Range
    Low 5.2111
    High 5.3000
  • 52 Week Range
    Low 4.0800
    High 6.5291
  • Volume
    6,975
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 5.215
TimeVolumeKMDA
10:06 ET31425.22
10:35 ET18005.3
11:45 ET1005.29
01:12 ET7125.28
02:26 ET1005.29
03:59 ET1005.3
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKMDA
Kamada Ltd
304.6M
20.7x
-22.48%
United StatesSTRO
Sutro Biopharma Inc
338.6M
-2.2x
---
United StatesAGEN
Agenus Inc
286.0M
-1.1x
---
United StatesTVTX
Travere Therapeutics Inc
469.0M
-1.2x
---
United StatesKPTI
Karyopharm Therapeutics Inc
123.6M
-0.8x
---
United StatesFGEN
FibroGen Inc
129.3M
-0.5x
---
As of 2024-05-27

Company Information

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Contact Information

Headquarters
2 Holtzman St., Science ParkREHOVOT, Israel 7670402
Phone
---
Fax
---

Executives

Chairman of the Board
Lilach Asher Topilsky
Chief Executive Officer
Amir London
Deputy Chairman of the Board
David Tsur
Chief Financial Officer
Chaime Orlev
Senior Vice President - Scientific Affairs
Ruth Wolfson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$304.6M
Revenue (TTM)
$149.5M
Shares Outstanding
57.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.06
EPS
$0.26
Book Value
$4.25
P/E Ratio
20.7x
Price/Sales (TTM)
2.0
Price/Cash Flow (TTM)
12.0x
Operating Margin
9.24%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.